Amorin Remus Popa

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Prevalence of diabetes mellitus and prediabetes in the adult <scp>R</scp>omanian population: <scp>PREDATORR</scp> study

Maria Moța, Simona Georgiana Popa, Eugen Moța et al. · Journal of Diabetes · 2015 · 140 citations

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Zien Zhou, Meg Jardine, Qiang Li et al. · Stroke · 2021 · 111 citations · Full text

What antibiotics for what pathogens? The sensitivity spectrum of isolated strains in an intensive care unit

Dana Carmen Zaha, Simona Bungău, Selim Aleya et al. · The Science of The Total Environment · 2019 · 62 citations · Full text

Pathogenic Microbiology, Sensitivity Spectrum, Antibiotics +10